Roth Capital Starts Cornerstone Therapeutics (CRTX) at Buy
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Roth Capital initiates coverage on Cornerstone Therapeutics (NASDAQ: CRTX) with a Buy. PT $8.
For more ratings news on Cornerstone Therapeutics click here and for the rating history of Cornerstone Therapeutics click here.
Shares of Cornerstone Therapeutics closed at $6.86 yesterday.
For more ratings news on Cornerstone Therapeutics click here and for the rating history of Cornerstone Therapeutics click here.
Shares of Cornerstone Therapeutics closed at $6.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
